U.S. markets open in 1 hour 3 minutes
  • S&P Futures

    3,878.50
    +11.00 (+0.28%)
     
  • Dow Futures

    31,482.00
    +124.00 (+0.40%)
     
  • Nasdaq Futures

    13,092.00
    +36.75 (+0.28%)
     
  • Russell 2000 Futures

    2,245.90
    +16.80 (+0.75%)
     
  • Crude Oil

    60.43
    +0.68 (+1.14%)
     
  • Gold

    1,709.60
    -24.00 (-1.38%)
     
  • Silver

    26.24
    -0.64 (-2.38%)
     
  • EUR/USD

    1.2054
    -0.0034 (-0.28%)
     
  • 10-Yr Bond

    1.4150
    0.0000 (0.00%)
     
  • Vix

    23.64
    +0.29 (+1.24%)
     
  • GBP/USD

    1.3963
    +0.0007 (+0.05%)
     
  • USD/JPY

    106.8920
    +0.1820 (+0.17%)
     
  • BTC-USD

    51,799.75
    +3,050.84 (+6.26%)
     
  • CMC Crypto 200

    1,034.15
    +46.06 (+4.66%)
     
  • FTSE 100

    6,654.59
    +40.84 (+0.62%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Lonza to sell Specialty Ingredients to Bain, Cinven in deal valued at 4.2 bln Sfr

  • Oops!
    Something went wrong.
    Please try again later.

ZURICH, Feb 8 (Reuters) - Bain Capital and Cinvenare acquiring Lonza's Specialty Ingredients unit in adeal valued at 4.2 billion Swiss francs ($4.67 billion), theSwiss contract drug maker said on Monday, as it focuses on itsfaster-growing drugs division.($1 = 0.8986 Swiss francs)(Reporting by John Miller; Editing by Leslie Adler)